Last reviewed · How we verify
Weekly Ferrous Sulfate
Weekly Ferrous Sulfate is a Iron supplement Small molecule drug developed by Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri. It is currently FDA-approved for Iron-deficiency anemia, Iron supplementation in pediatric populations. Also known as: Fer-in-sol.
Ferrous sulfate provides bioavailable iron to replenish depleted iron stores and restore hemoglobin synthesis.
Weekly Ferrous Sulfate is a small molecule supplement used to treat conditions such as anemia, iron deficiency, and iron deficiency anemia. It is available in tablet form and has been studied in clinical trials for its safety and efficacy in treating various iron-related conditions.
At a glance
| Generic name | Weekly Ferrous Sulfate |
|---|---|
| Also known as | Fer-in-sol |
| Sponsor | Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri |
| Drug class | Iron supplement |
| Target | Iron (Fe2+) for hemoglobin synthesis |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Mechanism of action
Ferrous sulfate is an iron supplement that delivers ferrous (Fe2+) iron, which is readily absorbed in the gastrointestinal tract. The absorbed iron is incorporated into hemoglobin and myoglobin, restoring oxygen-carrying capacity and correcting iron-deficiency anemia. The weekly formulation likely uses a sustained-release or modified-release mechanism to improve tolerability and compliance.
Approved indications
- Iron-deficiency anemia
- Iron supplementation in pediatric populations
Common side effects
- Gastrointestinal upset (nausea, abdominal discomfort)
- Constipation
- Dark stools
- Diarrhea
Key clinical trials
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA (NA)
- The Benefit in Terms of Improvement in Haemoglobin Level at 6 Months in Premature Babies Receiving Alternate Iron Substitution 4 Times a Week Compared to a Daily Substitution (NA)
- Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers (NA)
- Nutritional Educational Program On Therapy in Iron Deficiency Anemia (NA)
- Iron Deficiency in Pediatric Celiac Disease: Diet vs. Iron Supplementation Trial (NA)
- Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis (NA)
- Aerobic Exercises on Persisted Post Burn Anemia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Weekly Ferrous Sulfate CI brief — competitive landscape report
- Weekly Ferrous Sulfate updates RSS · CI watch RSS
- Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri portfolio CI
Frequently asked questions about Weekly Ferrous Sulfate
What is Weekly Ferrous Sulfate?
How does Weekly Ferrous Sulfate work?
What is Weekly Ferrous Sulfate used for?
Who makes Weekly Ferrous Sulfate?
Is Weekly Ferrous Sulfate also known as anything else?
What drug class is Weekly Ferrous Sulfate in?
What development phase is Weekly Ferrous Sulfate in?
What are the side effects of Weekly Ferrous Sulfate?
What does Weekly Ferrous Sulfate target?
Related
- Drug class: All Iron supplement drugs
- Target: All drugs targeting Iron (Fe2+) for hemoglobin synthesis
- Manufacturer: Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Iron-deficiency anemia
- Indication: Drugs for Iron supplementation in pediatric populations
- Also known as: Fer-in-sol
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing